Skip to content
10-Q

Quarterly Report

Myovant Sciences Ltd.

0001679082-21-000043

← back to feed
Filed
Oct 26, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Oct 22, 2021 93.31M sh
Current Liabilities Q2 2022 · Sep 30, 2021 $268.34M
Current Liabilities Q2 2022 · Mar 31, 2021 $281.34M
Total Liabilities Q2 2022 · Sep 30, 2021 $1.06B
Total Liabilities Q2 2022 · Mar 31, 2021 $1.08B
Current Assets Q2 2022 · Sep 30, 2021 $654.67M
Current Assets Q2 2022 · Mar 31, 2021 $704.65M
Total Assets Q2 2022 · Sep 30, 2021 $679.54M
Total Assets Q2 2022 · Mar 31, 2021 $725.03M
Cash And Equivalents Q2 2022 · Mar 31, 2021 $674.49M
Cash And Equivalents Q2 2022 · Sep 30, 2020 $94.21M
Shares Diluted Q2 2022 · Sep 30, 2020 89.74M sh
Shares Diluted Q2 2022 · Sep 30, 2020 89.52M sh
Capex Q2 2022 · Sep 30, 2020 $734K
Operating Cash Flow Q2 2022 · Sep 30, 2020 −$110.58M
Stockholders Equity Q2 2022 · Sep 30, 2020 −$199.78M
Stockholders Equity Q2 2022 · Jun 30, 2020 −$134.61M
Stockholders Equity Q2 2022 · Mar 31, 2020 −$108.28M
Eps Diluted Q2 2022 · Sep 30, 2020 −$0.75
Eps Diluted Q2 2022 · Sep 30, 2020 −$1.12
Eps Basic Q2 2022 · Sep 30, 2020 −$0.75
Eps Basic Q2 2022 · Sep 30, 2020 −$1.12
Sga Expense Q2 2022 · Sep 30, 2020 $31.32M
Sga Expense Q2 2022 · Sep 30, 2020 $54.14M
Rd Expense Q2 2022 · Sep 30, 2020 $40.52M
Rd Expense Q2 2022 · Sep 30, 2020 $84.71M
Net Income Q2 2022 · Sep 30, 2020 −$67.06M
Net Income Q2 2022 · Sep 30, 2020 −$99.92M
Net Income Q2 2022 · Jun 30, 2020 −$32.86M
Operating Income Q2 2022 · Sep 30, 2020 −$71.84M
Operating Income Q2 2022 · Sep 30, 2020 −$105.52M